Chart Industries (NYSE:GTLS – Get Free Report) issued an update on its FY24 earnings guidance on Friday morning. The company provided EPS guidance of ~$9.00 for the period, compared to the consensus EPS estimate of $10.14. The company issued revenue guidance of $4.20-4.30 billion, compared to the consensus revenue estimate of $4.40 billion. Chart Industries also updated its FY 2024 guidance to 9.000-9.000 EPS.
Chart Industries Stock Up 5.3 %
Shares of GTLS traded up $6.90 on Monday, reaching $136.90. The stock had a trading volume of 823,793 shares, compared to its average volume of 624,952. The firm has a market capitalization of $5.86 billion, a price-to-earnings ratio of 39.68, a price-to-earnings-growth ratio of 0.56 and a beta of 1.71. The company has a 50-day simple moving average of $121.62 and a 200-day simple moving average of $136.98. Chart Industries has a 12-month low of $101.60 and a 12-month high of $171.68. The company has a debt-to-equity ratio of 1.28, a quick ratio of 0.98 and a current ratio of 1.27.
Chart Industries (NYSE:GTLS – Get Free Report) last announced its earnings results on Friday, November 1st. The industrial products company reported $2.18 EPS for the quarter, missing analysts’ consensus estimates of $2.56 by ($0.38). The business had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.10 billion. Chart Industries had a net margin of 2.80% and a return on equity of 12.27%. The business’s quarterly revenue was up 18.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.28 EPS. Sell-side analysts predict that Chart Industries will post 9.94 EPS for the current year.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on GTLS
Insider Transactions at Chart Industries
In other news, CEO Jillian C. Evanko bought 440 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was bought at an average price of $114.31 per share, with a total value of $50,296.40. Following the acquisition, the chief executive officer now owns 125,448 shares of the company’s stock, valued at approximately $14,339,960.88. This represents a 0.00 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, Director Paul E. Mahoney bought 500 shares of the business’s stock in a transaction that occurred on Wednesday, September 11th. The stock was bought at an average cost of $106.55 per share, with a total value of $53,275.00. Following the completion of the purchase, the director now owns 2,107 shares of the company’s stock, valued at approximately $224,500.85. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jillian C. Evanko acquired 440 shares of the business’s stock in a transaction dated Thursday, September 5th. The shares were purchased at an average price of $114.31 per share, with a total value of $50,296.40. Following the transaction, the chief executive officer now owns 125,448 shares of the company’s stock, valued at approximately $14,339,960.88. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 7,152 shares of company stock valued at $482,278 over the last three months. Corporate insiders own 0.95% of the company’s stock.
Chart Industries Company Profile
Chart Industries, Inc engages in the designing, engineering, and manufacturing of process technologies and equipment for the gas and liquid molecules in the United States and internationally. The company operates in four segments: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products, and Repair, Service & Leasing.
See Also
- Five stocks we like better than Chart Industries
- What is the FTSE 100 index?
- Intel: Is Now the Time to Be Brave?Â
- Investing In Automotive Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Chart Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chart Industries and related companies with MarketBeat.com's FREE daily email newsletter.